
Auteur C. PULJEVIC
|
Documents disponibles écrits par cet auteur (4)

A. R. WINSTOCK ; L. J. MAIER ; A. ZHUPARRIS ; E. DAVIES ; C. PULJEVIC ; K. P. C. KUYPERS ; J. A. FERRIS ; M. J. BARRATT | 2021
RapportData collection period: GDS2021 ran between December 2020 and March 2021. Sample characteristics Global Drug Survey 2021 (GDS2021): Data from over 32,000 people from over 20 countries were used in the preparation of this report. 62% were cisg[...]
C. PULJEVIC ; A. SNOSWELL ; L. RIVAS ; M. M. ALI ; W. DE GREEF ; J. FERRIS ; C. GARTNER | 2021
Dans Drug and Alcohol Review (Vol.40, n°7, November 2021) Article : PériodiqueINTRODUCTION: High rates of tobacco smoking among people who are homeless or living in temporary accommodation exacerbate poor health outcomes and financial disadvantage. There is limited research on this population's perceptions of smoking cess[...]
C. PULJEVIC ; A. COSSART ; E. L. DAVIES ; M. J. BARRATT ; L. J. MAIER ; M. JAUFFRET-ROUSTIDE ; A. R. WINSTOCK ; J. A. FERRIS | 2023
Dans Drugs, Habits and Social Policy (Vol.24, n°3, 2023) Article : PériodiquePurpose: The COVID-19 pandemic likely impacted cannabis distribution, access and usage worldwide. This study aims to describe self-reported changes in cannabis use and related outcomes following COVID-19-related restrictions among an internation[...]
C. PULJEVIC ; D. STJEPANOVIC ; I. MECIAR ; H. KANG ; G. CHAN ; K. MORPHETT ; H. BENDOTTI ; G. KUNWAR ; C. GARTNER | 2024
Dans Addiction (Vol.119, n°10, October 2024) Article : PériodiqueBACKGROUND AND AIMS: Cytisine (also known as cytisinicline) is a low-cost partial agonist of nicotinic acetylcholine receptors used to assist tobacco cessation. We aimed to review the effectiveness of cytisine for tobacco cessation and the effec[...]